Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer patients treated with primary or interval cytoreductive surgery(☆)

BACKGROUND: Ovarian cancer remains the most lethal gynecologic malignancy with high recurrence rates. Because recurrence involves primarily the peritoneum, intraperitoneal chemotherapy is being evaluated as a new approach to treat microscopic peritoneal disease. One trial showed that cisplatin–pacli...

Descripción completa

Detalles Bibliográficos
Autores principales: El Hajj, H., Vanseymortier, M., Hudry, D., Bogart, E., Abdeddaim, C., Leblanc, E., Le Deley, M.C., Narducci, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047490/
https://www.ncbi.nlm.nih.gov/pubmed/33819750
http://dx.doi.org/10.1016/j.esmoop.2021.100098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047490/
https://www.ncbi.nlm.nih.gov/pubmed/33819750
http://dx.doi.org/10.1016/j.esmoop.2021.100098

Ejemplares similares